COMPANY

Sanguine Biosciences

HQ: San Diego, CA source · sanguinebio.com ↗

Sanguine supplies fresh human whole blood samples from healthy and disease-state donors, with same-day collection available. From company website Source · Oct 12, 2026

Keywords: Multiple Sclerosis Sickle Cell Disease Sickle Cell Anemia Ankylosing Spondylitis Alopecia Areata Asthma Beta-Thalassemia Celiac Disease Cystic Fibrosis Leukemia Lymphoma Psoriasis Scleroderma Ulcerative Colitis Chronic Kidney Diseases Colorectal Cancer Huntington's Disease Parkinson's Disease Mucopolysaccharidosis III-A Rare Diseases Age-Related Macular Degeneration Allergies Alpha-Gal Syndrome Alzheimer Disease Amyloidosis Arthritis Atopic Dermatitis Autism Autoimmune Hepatitis Behcet's Disease Kidney Diseases COPD Crohn Disease Diabetes Dravet Syndrome DMD Fibromyalgia Graves Disease Thyroid Diseases Hepatitis

Profile checked Oct 10, 2026

13Trials (company is sponsor)

Timeline

May 24, 2023 Trial start —: Whole Blood Biospecimen Collection for Subjects With Fanconi Anemia source ↗
May 23, 2023 Trial start —: Whole Blood Biospecimen Collection for Subjects With Chronic Granulomatous Disease (CGD) source ↗
Apr 27, 2023 Trial start —: Prospective Collection of Biospecimen in Pediatric Patients and Adult Guardians Diagnosed With Glycogen Storage Disease Type 1B (GSD1b) source ↗
Mar 27, 2023 Trial start —: Study SBX-01-101: A Stool Collection Study in Colorectal Cancer (CRC) Patients Treated With Irinotecan-Based Regimens source ↗
Mar 14, 2023 Trial start —: Prospective Single-Timepoint Huntington's Disease Biospecimen Collection Study source ↗
Dec 15, 2022 Trial start —: Biorepository of Biospecimen Samples in Matched Healthy Control Participants and Participants Diagnosed With Diabetic Kidney Disease, Chronic Kidney Disease, or Type 2 Diabetes source ↗
Sep 28, 2022 Trial start —: A Multi-Site Leukopak Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives source ↗
Sep 27, 2022 Trial start —: A Natural History Study of Biomarkers and Clinical Outcomes in Mucopolysaccharidosis Type IIIA (MPS IIIA; Sanfilippo Syndrome) source ↗
Feb 19, 2022 Trial start —: Prospective Collection of Whole Blood From Active Non-Small Cell Lung Cancer Patients for Supplemental Research source ↗
Jan 19, 2022 Trial start —: A Low-Interventional Study of an Electronic Sickle Cell Disease Patient Reported Outcomes in Sickle Cell Participants source ↗
Oct 26, 2021 Trial start —: Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives source ↗
2013-07 Trial start —: At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions source ↗
2011-11 Trial start —: A Biospecimen and Clinical Data Study on Patients for Drug & Biomarker Discovery source ↗

Upcoming milestones

Dec 31, 2026 (ESTIMATED) · · A Multi-Site Leukopak Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives · NCT05794217

Estimated primary completion per ClinicalTrials.gov. Dates move.

Clinical trials (lead sponsor) 13

Record	Title	Phase	Status	Start	Primary completion
NCT05523206	A Natural History Study of Biomarkers and Clinical Outcomes in Mucopolysaccharidosis Type IIIA (MPS IIIA; Sanfilippo Syndrome)	Not listed	Completed	Sep 27, 2022	Dec 19, 2024 (actual)
NCT05794217	A Multi-Site Leukopak Repository Providing Annotated Biospecimens for Approved Investigator-Directed Biomedical Research Initiatives	Not listed	Recruiting	Sep 28, 2022	Dec 31, 2026 (estimated)
NCT06503458	A Low-Interventional Study of an Electronic Sickle Cell Disease Patient Reported Outcomes in Sickle Cell Participants	Not listed	Terminated	Jan 19, 2022	Dec 23, 2023 (actual)
NCT05635266	Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives	Not listed	Unknown status (ClinicalTrials.gov)	Oct 26, 2021	2025-10 (estimated)
NCT05915910	Prospective Collection of Biospecimen in Pediatric Patients and Adult Guardians Diagnosed With Glycogen Storage Disease Type 1B (GSD1b)	Not listed	Terminated	Apr 27, 2023	Mar 13, 2024 (actual)
NCT05915897	Whole Blood Biospecimen Collection for Subjects With Chronic Granulomatous Disease (CGD)	Not listed	Terminated	May 23, 2023	Mar 25, 2024 (actual)
NCT05910853	Whole Blood Biospecimen Collection for Subjects With Fanconi Anemia	Not listed	Terminated	May 24, 2023	Mar 12, 2024 (actual)
NCT05773196	Prospective Single-Timepoint Huntington's Disease Biospecimen Collection Study	Not listed	Unknown status (ClinicalTrials.gov)	Mar 14, 2023	Feb 28, 2025 (estimated)
NCT01931644	At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions	Not listed	Completed	2013-07	2024-04 (actual)
NCT05669105	Prospective Collection of Whole Blood From Active Non-Small Cell Lung Cancer Patients for Supplemental Research	Not listed	Unknown status (ClinicalTrials.gov)	Feb 19, 2022	Mar 31, 2024 (estimated)
NCT01592552	A Biospecimen and Clinical Data Study on Patients for Drug & Biomarker Discovery	Not listed	Completed	2011-11	2015-03 (actual)
NCT05821582	Study SBX-01-101: A Stool Collection Study in Colorectal Cancer (CRC) Patients Treated With Irinotecan-Based Regimens	Not listed	Withdrawn	Mar 27, 2023	Oct 5, 2023 (actual)
NCT05631119	Biorepository of Biospecimen Samples in Matched Healthy Control Participants and Participants Diagnosed With Diabetic Kidney Disease, Chronic Kidney Disease, or Type 2 Diabetes	Not listed	Completed	Dec 15, 2022	Aug 23, 2023 (actual)

Connect

Contact page